See also this year's filing and all EDGAR filings for this company.
PDF Report 0001636282_2025_Spyre_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001636282, Spyre Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 608,474,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 10,000 |
| 4 | LiabilitiesCurrent | 54,060,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 36,620,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 53,154,541 |
| 9 | ResearchAndDevelopmentExpense | 528,290,278 |
| 10 | remainder_Expenses | 111,676,219 |
| 11 | remainder_Revenues | 282,961 |
| 12 | remainder_NetIncome | -94,838,567 |
| 13 | remainder_ComprehensiveNetIncome | 340,908 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 608,484,000 |
| 1 | Liabilities | 90,680,000 |
| 2 | Expenses | 693,121,038 |
| 3 | Revenues | 282,961 |
| 4 | StockholdersEquity | 517,804,000 |
| 5 | NetIncome | -787,676,644 |
| 6 | ComprehensiveNetIncome | -787,506,190 |
| 7 | BaseVar | 743,873,737 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.976 |
| 9 | EconomicCapitalRatio | 2.28 |
Edgar->Model Mapping
Feature Distribution
Change over Time
